KOARMVI Trademark
KOARMVI is a USPTO trademark filed by Pfizer Inc.. Status: Abandoned.
Trademark Facts
| Mark | KOARMVI |
|---|---|
| Serial Number | 98704971 |
| Status | Abandoned |
| Filing Date | 2024-08-19 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Pfizer Inc. |
| Attorney of Record | Tiffany Trunko |
| Prosecution Events | 12 |
| Latest Event | ETOP on 2025-02-22 |
Goods & Services
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
Recent Prosecution Activity
| Date | Code | Type | Description |
|---|---|---|---|
| 2025-02-22 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 2025-01-25 | MAB5 | E | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| 2025-01-25 | ABN5 | O | ABANDONMENT - AFTER PUBLICATION |
| 2025-01-24 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED |
| 2025-01-21 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 2024-12-24 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2024-12-24 | PUBO | A | PUBLISHED FOR OPPOSITION |
| 2024-12-18 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2024-11-30 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2024-11-25 | DOCK | D | ASSIGNED TO EXAMINER |
Other Trademarks from Pfizer Inc.
Pfizer Inc. owns 5 USPTO trademarks (5 live).
- VOCINBEQ — Pending (filed 2026-05-11)
- ONTELIAN — Pending (filed 2026-05-07)
- LAGHENO — Pending (filed 2026-05-05)
- OPROVDA — Pending (filed 2026-05-05)
- AIM2 DISCOVERY CENTER — Pending (filed 2026-04-23)
Nice Class Context
- Class 005 (Pharmaceuticals) — 182960 live marks in this class